Adverse Outcomes of Assisted Reproductive Technologies (P01)

The summary for the Adverse Outcomes of Assisted Reproductive Technologies (P01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Adverse Outcomes of Assisted Reproductive Technologies (P01)
	CFDA Number:	93.865
	CFDA Description:	Child Health and Human Development Extramural Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health Income Security and Social Services
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PA-08-103
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Dec 03, 2008
	Creation Date:	Dec 03, 2008
	Original Closing Date for Applications:	May 07, 2011
	Current Closing Date for Applications:	May 07, 2011
	Archive Date:	Jun 07, 2011
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; *Program project grants to foreign institutions are not allowed, although component projects located at foreign institutions are allowed with appropriate justification.
Grant Description: Purpose. This Funding Opportunity Announcement (FOA), issued by the National Institute of Child Health and Human Development (NICHD), encourages Program Project Grant (P01) applications from institutions/organizations that propose to study the ways in which Assisted Reproductive Technologies (ART) may affect eggs, sperm and preimplantation embryos that could, in turn, lead to adverse outcomes during fetal development, the perinatal period, childhood, adulthood or even subsequent generations. While most ART offspring appear to be healthy and developing normally, there are some reports of adverse outcomes and some concerns owing to the variety and type of ART protocols in use. This FOA encourages applications on human subjects and animal models that can include a wide variety of basic, clinical and epidemiological approaches. P01 applicants can take advantage of this FOA to propose multidisciplinary, interactive and synergistic program projects in order to address some of these issues. It is anticipated that this FOA will provide empirical data for understanding ART outcomes and also how reproductive health is fundamental to overall health and quality of life.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/pa-08-103.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Biomedical/Biobehavioral Research Administration Development (BRAD) Award [G11]; • Rehabilitation Research Career Development Programs (K12); • Pediatric Scientist Development Program (PSDP) [K12]; • Translational Research in Pediatric and Obstetric Pharmacology (R21); • Translational Research in Pediatric and Obstetric Pharmacology (R01); • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Preclinical Stud...; • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Preclinical Stud...; • REPRODUCTIVE GENETICS AND EPIGENETICS; • DEVELOPMENTAL MECHANISMS OF HUMAN STRUCTURAL BIRTH DEFECTS; • ENDOMETRIAL CELL FUNCTION